Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Patrick G. Enright reported a 7.00% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Patrick G. Enright reported a 7.00% stake in Cytomx Therapeutics, Inc., 15,288,461 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
7.00%
Shares
15,288,461
Intent
Passive
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Longitude Capital Partners V, LLC5.70%12,458,461
Longitude Venture Partners V, L.P.5.70%12,458,461
Longitude 103.8 East Partners, LLC1.30%2,830,000
Longitude 103.8 East, L.P.1.30%2,830,000
Patrick G. Enright7.00%15,288,461
Juliet Tammenoms Bakker7.00%15,288,461

Source

View original at SEC

Related